Looking for Mounjaro for Less? Here's What You Actually Need to Know

Why has the price of Mounjaro gone up, and what does the market actually look like now?

Eli Lilly raised its UK list price for Mounjaro from 1 September 2025. The highest-dose pen, which previously listed at around £122, moved to around £330, a shift that rippled through every private provider almost immediately. Typical private prices now sit somewhere between £149 and £375 per month by dose, as widely reported at the time of the change.

That's a wide range, and it tells you something useful. The gap between providers isn't just margin, it often reflects what's bundled in. Some headline prices exclude the consultation fee, the prescription charge, delivery, and any ongoing clinical monitoring. Add those separately and a seemingly low entry price looks less attractive. On the other hand, some providers genuinely do charge more than the medicine alone warrants. It's worth asking for a clear breakdown before you commit to anything.

At nume, the price shown on the treatment page includes the consultation, the prescription, next-working-day tracked delivery, and aftercare seven days a week, no extras added at checkout. Whether that makes us right for you depends on your circumstances, not just the number.

Is there a safe way to pay less, or are 'Mounjaro deals' a red flag?

This is the misconception worth addressing gently: that there's a clever route to a lower price if you look hard enough. Social media sellers, discount codes attached to weight-loss medicines, and prices significantly below the market range are not bargains. They are red flags.

The MHRA has been explicit about this. In October 2025, enforcement teams raided an illicit manufacturing site producing counterfeit tirzepatide pens, part of a wider operation that seized roughly 20 million doses of illegally traded weight-loss medicines with a street value of around £45 million. Fake pens have previously been found to contain entirely the wrong substance. The risk isn't theoretical.

You can verify any online pharmacy in under a minute using the GPhC pharmacy register. If a seller can't be found there, they shouldn't be supplying you with a prescription medicine. Suspect sellers can also be reported directly through the MHRA's Yellow Card scheme.

Discount codes for prescription medicines from unverified sources are consistently cited by the MHRA as a warning sign. nume doesn't run codes, vouchers or promotional pricing on treatments, not because we forgot, but because it isn't how a clinical service should work.

Does paying less mean you'll get less from the treatment itself?

The clinical evidence for tirzepatide is strong by any measure. In the SURMOUNT-1 trial, participants at the highest dose saw an average body-weight reduction of around 20–21% over 72 weeks, results that sit at the top of what any licensed weight-management medicine has produced. The tirzepatide overview covers the evidence in more detail, including how those results compare to semaglutide.

But those results came from a supervised clinical programme with regular monitoring, dietary support, and activity guidance alongside the medicine. The medicine alone, unsupervised, bought from a seller who never assessed you, is not the same thing, legally or practically. Under UK licensing, Mounjaro is indicated for adults with a BMI of 30 or above, or 27 or above with at least one weight-related condition such as high blood pressure, type 2 diabetes or obstructive sleep apnoea. Lower BMI thresholds may apply for some ethnic backgrounds under NICE guidance.

If Mounjaro becomes less effective over time or your response plateaus, a prescriber can help you understand why, you can read more about how effectiveness can change. Some people also find it helpful to understand how weightless Mounjaro programmes are structured and what ongoing support typically looks like alongside the medicine. That kind of ongoing clinical relationship isn't something a cheap one-off sale provides.

So what's the smartest way to approach cost when starting Mounjaro?

Think about the full picture over the treatment period, not just the first pen. NHS guidance on weight management injections makes clear that these medicines work best alongside dietary and activity changes, building those habits in parallel means you're not wholly dependent on the medicine indefinitely.

On the NHS, tirzepatide access is being rolled out in phases and criteria are strict. The current cohort requires a BMI of 40 or above with four or more qualifying conditions. If you don't meet those criteria, or you'd rather not wait, private treatment through a regulated pharmacy is the legal alternative. Not every private provider is the same, though. Look for one you can verify on the register, one that reviews you clinically before every order, and one that has genuine aftercare in place. It's also worth knowing that some people notice unexpected symptoms during treatment, and if you want to understand whether Mounjaro can cause restless leg, that's a question our clinical team can help you work through. For a fuller picture of the relationship between Mounjaro and restless legs, including what the current evidence suggests, there's dedicated guidance available.

Men sometimes ask different questions about cost and effectiveness, the Mounjaro for men page covers some of the practical considerations. And if you want a broader view of what's available, the weight-loss treatment overview sets out the landscape.

When you're ready to find out whether Mounjaro is clinically suitable for you, check your eligibility with our prescribers, the consultation is free and reviewed the same day by a real clinician.